NeonMind Biosciences Valuation
| NMDBFDelisted Stock | USD 0.50 0.00 0.00% |
NeonMind Biosciences is overvalued. NeonMind Biosciences secures a last-minute Real Value of $0.35 per share. The latest price of the firm is $0.5. Our model forecasts the value of NeonMind Biosciences from analyzing the firm fundamentals such as Return On Equity of -37.22, operating margin of 735.17 %, and Shares Outstanding of 35.82 M as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that NeonMind Biosciences' price fluctuation is very steady at this time. Calculation of the real value of NeonMind Biosciences is based on 3 months time horizon. Increasing NeonMind Biosciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the NeonMind pink sheet is determined by what a typical buyer is willing to pay for full or partial control of NeonMind Biosciences. Since NeonMind Biosciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of NeonMind Pink Sheet. However, NeonMind Biosciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.5 | Real 0.35 | Hype 0.5 | Naive 0.57 |
The real value of NeonMind Pink Sheet, also known as its intrinsic value, is the underlying worth of NeonMind Biosciences Company, which is reflected in its stock price. It is based on NeonMind Biosciences' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of NeonMind Biosciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of NeonMind Biosciences helps investors to forecast how NeonMind pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of NeonMind Biosciences more accurately as focusing exclusively on NeonMind Biosciences' fundamentals will not take into account other important factors: NeonMind Biosciences Total Value Analysis
NeonMind Biosciences is now forecasted to have takeover price of 799.08 K with market capitalization of 272.23 K, debt of 450.01 K, and cash on hands of 89.22 K. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the NeonMind Biosciences fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
799.08 K | 272.23 K | 450.01 K | 89.22 K |
NeonMind Biosciences Asset Utilization
One of the ways to look at asset utilization of NeonMind is to check how much profit was generated for every dollar of assets it reports. NeonMind Biosciences secures a negative usage of assets of -1.88 %, losing $0.0188 for each dollar of assets held by the firm. Inadequate asset utilization conveys that the company is being less effective with each dollar of assets it secures. Strictly speaking, asset utilization of NeonMind Biosciences shows how discouraging it operates for each dollar spent on its assets.NeonMind Biosciences Profitability Analysis
Net Loss for the year was (7.21 M) with loss before overhead, payroll, taxes, and interest of (84.45 K).Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates NeonMind Biosciences' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in NeonMind Biosciences and how it compares across the competition.
About NeonMind Biosciences Valuation
The pink sheet valuation mechanism determines NeonMind Biosciences' current worth on a weekly basis. Our valuation model uses a comparative analysis of NeonMind Biosciences. We calculate exposure to NeonMind Biosciences's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of NeonMind Biosciences's related companies.NeonMind Biosciences Inc. engages in the discovery, development, and commercialization of medicinal and psychedelic mushrooms for mental illnesses. NeonMind Biosciences Inc. is a subsidiary of The Yield Growth Corp. Neonmind Biosciences is traded on OTC Exchange in the United States.
8 Steps to conduct NeonMind Biosciences' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates NeonMind Biosciences' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct NeonMind Biosciences' valuation analysis, follow these 8 steps:- Gather financial information: Obtain NeonMind Biosciences' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine NeonMind Biosciences' revenue streams: Identify NeonMind Biosciences' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research NeonMind Biosciences' industry and market trends, including the size of the market, growth rate, and competition.
- Establish NeonMind Biosciences' growth potential: Evaluate NeonMind Biosciences' management, business model, and growth potential.
- Determine NeonMind Biosciences' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate NeonMind Biosciences' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
NeonMind Biosciences Growth Indicators
Investing in growth stocks can be very risky. If the company such as NeonMind Biosciences does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 31.7 M | |
| Retained Earnings | -13.1 M |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Consideration for investing in NeonMind Pink Sheet
If you are still planning to invest in NeonMind Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the NeonMind Biosciences' history and understand the potential risks before investing.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |